Apellis Pharmaceuticals, Inc. reports

Apellis Pharmaceuticals, Inc. has filed 1,032 SEC EDGAR filings since 5/21/2010

Form type	Sec Links	Description	Filing date	Reporting date
10-Q	Report \| Data	10-Q	May 7, 2025	Mar 31, 2025
10-Q	Report \| Data	10-Q	Nov 5, 2024	Sep 30, 2024
10-Q	Report \| Data	10-Q	Aug 1, 2024	Jun 30, 2024
10-Q	Report \| Data	10-Q	May 7, 2024	Mar 31, 2024
10-Q	Report \| Data	10-Q	Nov 1, 2023	Sep 30, 2023
10-Q	Report \| Data	10-Q	Jul 31, 2023	Jun 30, 2023
10-Q	Report \| Data	10-Q	May 4, 2023	Mar 31, 2023
10-Q	Report \| Data	10-Q	Nov 7, 2022	Sep 30, 2022
10-Q	Report \| Data	10-Q	Aug 8, 2022	Jun 30, 2022
10-Q	Report \| Data	10-Q	May 4, 2022	Mar 31, 2022
10-Q	Report \| Data	10-Q	Nov 8, 2021	Sep 30, 2021
10-Q	Report \| Data	10-Q	Aug 9, 2021	Jun 30, 2021
10-Q	Report \| Data	10-Q	Apr 28, 2021	Mar 31, 2021
10-Q	Report \| Data	10-Q	Nov 2, 2020	Sep 30, 2020
10-Q	Report \| Data	10-Q	Jul 30, 2020	Jun 30, 2020
10-Q	Report \| Data	10-Q	Apr 29, 2020	Mar 31, 2020
10-Q	Report \| Data	10-Q	Nov 5, 2019	Sep 30, 2019
10-Q	Report \| Data	10-Q	Jul 31, 2019	Jun 30, 2019
10-Q	Report \| Data	10-Q	May 7, 2019	Mar 31, 2019
10-Q	Report \| Data	10-Q	Nov 13, 2018	Sep 30, 2018
10-Q	Report \| Data	10-Q	Jul 31, 2018	Jun 30, 2018
10-Q	Report \| Data	10-Q	Apr 30, 2018	Mar 31, 2018
10-Q	Report \| Data	10-Q	Dec 20, 2017	Sep 30, 2017

Showing 1 to 23 of 23 entries